Stella Xu is Director at Design Therapeutics, Inc. (DSGN). They have made 3 open-market trades across 2 companies since 2019, most recently 2022-03-22.
CIK 0001728741
2 open-market purchases totalling $2.1M since 2019, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.